These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 10318658)

  • 1. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
    de Jong SC; Stehouwer CD; van den Berg M; Kostense PJ; Alders D; Jakobs C; Pals G; Rauwerda JA
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
    Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
    Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease.
    Haraki T; Takegoshi T; Kitoh C; Kajinami K; Wakasugi T; Hirai J; Shimada T; Kawashiri M; Inazu A; Koizumi J; Mabuchi H
    Clin Nephrol; 2001 Aug; 56(2):132-9. PubMed ID: 11522090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
    Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
    Verhoef P; Kok FJ; Kluijtmans LA; Blom HJ; Refsum H; Ueland PM; Kruyssen DA
    Atherosclerosis; 1997 Jul; 132(1):105-13. PubMed ID: 9247365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism.
    Hustad S; Ueland PM; Vollset SE; Zhang Y; Bjørke-Monsen AL; Schneede J
    Clin Chem; 2000 Aug; 46(8 Pt 1):1065-71. PubMed ID: 10926884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.
    Morelli VM; Lourenço DM; D'Almeida V; Franco RF; Miranda F; Zago MA; Noguti MA; Cruz E; Kerbauy J
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):271-5. PubMed ID: 11943942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.
    Lim PS; Hung WR; Wei YH
    Nephron; 2001 Mar; 87(3):249-56. PubMed ID: 11287760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study.
    Dekou V; Whincup P; Papacosta O; Ebrahim S; Lennon L; Ueland PM; Refsum H; Humphries SE; Gudnason V
    Atherosclerosis; 2001 Feb; 154(3):659-66. PubMed ID: 11257267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The common mutations C677T and A1298C in the human methylenetetrahydrofolate reductase gene are associated with hyperhomocysteinemia and cardiovascular disease in hemodialysis patients.
    Haviv YS; Shpichinetsky V; Goldschmidt N; Atta IA; Ben-Yehuda A; Friedman G
    Nephron; 2002 Sep; 92(1):120-6. PubMed ID: 12187094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
    Domagala TB; Adamek L; Nizankowska E; Sanak M; Szczeklik A
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):423-31. PubMed ID: 12138370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke.
    Pezzini A; Del Zotto E; Archetti S; Negrini R; Bani P; Albertini A; Grassi M; Assanelli D; Gasparotti R; Vignolo LA; Magoni M; Padovani A
    Stroke; 2002 Mar; 33(3):664-9. PubMed ID: 11872884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction.
    Girelli D; Friso S; Trabetti E; Olivieri O; Russo C; Pessotto R; Faccini G; Pignatti PF; Mazzucco A; Corrocher R
    Blood; 1998 Jun; 91(11):4158-63. PubMed ID: 9596662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.
    Weger M; Stanger O; Deutschmann H; Leitner FJ; Renner W; Schmut O; Semmelrock J; Haas A
    Am J Ophthalmol; 2002 Jul; 134(1):57-61. PubMed ID: 12095808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population.
    Inamoto N; Katsuya T; Kokubo Y; Mannami T; Asai T; Baba S; Ogata J; Tomoike H; Ogihara T
    Stroke; 2003 Jul; 34(7):1628-33. PubMed ID: 12775885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.
    Jacques PF; Kalmbach R; Bagley PJ; Russo GT; Rogers G; Wilson PW; Rosenberg IH; Selhub J
    J Nutr; 2002 Feb; 132(2):283-8. PubMed ID: 11823591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.